𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bilateral breast carcinoma : Risk factors and outcomes for patients with synchronous and metachronous disease

✍ Scribed by Dwight E. Heron; Lydia T. Komarnicky; Terry Hyslop; Gordon F. Schwartz; Carl M. Mansfield


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
345 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


p53 and vascular-endothelial-growth-fact
✍ Barbro Linderholm; Birgitta Lindh; BjΓΆrn Tavelin; Kjell Grankvist; Roger Henriks πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 169 KB

The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between

The relation between the presence and ex
✍ Anthony L. Abner; James L. Connolly; Abram Recht; Bruce Bornstein; Asa Nixon; St πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Background: When found in an otherwise benign biopsy, lobular carcinoma in situ (lcis) has been associated with an increased risk of development of a subsequent invasive breast carcinoma. however, the association between lcis and the risk of subsequent local recurrence in patients with infiltrat

The prognostic value of p53 and c-erb b-
✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 1 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly